Us Bancorp »

Rapport Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $583 14 41.64
2025-03-31 $1.4k 144 10.03

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
JPMorgan Chase & Co. (JPM)

View all positions for Us Bancorp

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Goldman Sachs Group
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vanguard Capital Management
Trv Gp Vi
State Street Corporation
Geode Capital Management

View all funds holding Rapport Therapeutics